Martin Javier San Athira Pharma, Inc. (ATHA) insider trading activity

Martin Javier San is CHIEF MEDICAL OFFICER of Athira Pharma, Inc.. Currently has a direct ownership of 10,189 shares of ATHA, which is worth approximately $46,971. The most recent transaction as insider was on Jan 02, 2026, when has been sold 1,644 shares (Common Stock) at a price of $6.88 per share, resulting in proceeds of $11,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.2K

85.78% 3M change

71.57% 12M change

Total Value Held $46,971

Martin Javier San Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Open market or private sale	$11,310 $6.88 p/Share	1,644 Reduced 13.89%	10,189 Common Stock
Dec 31 2025	BUY Exercise of conversion of derivative security	-	4,667 Added 28.28%	11,833 Common Stock
Jul 01 2025	SELL Open market or private sale	$3,144 $0.29 p/Share	10,842 Reduced 13.14%	71,665 Common Stock
Jun 30 2025	BUY Exercise of conversion of derivative security	-	46,666 Added 36.13%	82,507 Common Stock
Jan 02 2025	SELL Open market or private sale	$6,062 $0.56 p/Share	10,826 Reduced 23.2%	35,841 Common Stock
Dec 31 2024	BUY Exercise of conversion of derivative security	-	46,667 Added 50.0%	46,667 Common Stock

Also insider at

ARWR

ARROWHEAD PHARMACEUTICALS, INC. Healthcare

Chief Medical Officer

MJS